More Company News

Mereo BioPharma

Successful Type B Meeting with U.S. FDA
15 Jul 2019Read More

Mereo BioPharma

Conversion of loan note and issue of equity
21 Jun 2019Read More

Mereo BioPharma

Update on etigilimab TIGIT partnership
13 Jun 2019Read More

Mereo BioPharma

Positive early 6-month data for BPS-804 (setrusumab) in OI
30 May 2019Read More

Mereo BioPharma

Publication of FY18 report and accounts
30 Apr 2019Read More

Mereo BioPharma

Preliminary FY18 results
29 Apr 2019Read More

Mereo BioPharma

Admission to trading on AIM of new shares and initiation of trading on NASDAQ of ADS
24 Apr 2019Read More

Mereo BioPharma

Completion of merger
23 Apr 2019Read More

Mereo BioPharma

Merger update
18 Apr 2019Read More

Mereo BioPharma

Successful end of Phase 2 meeting with FDA
15 Apr 2019Read More

1 2
Return to Mereo BioPharma
© 2019 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).